Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit

Clinical Pharmacology and Therapeutics

Volumn 62, Issue 5, 1997, Pages 546-555

  Appel, Silke ^a   Kumle, Anette ^b   Meier, Remy ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROKINETIC AGENT; TEGASEROD; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DEFECATION; DIET; DOSE RESPONSE; FECES ANALYSIS; GASTROINTESTINAL MOTILITY; HEADACHE; HIGH FIBER DIET; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL;

ADULT; COLON; DIETARY FIBER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; GASTROINTESTINAL TRANSIT; HUMANS; INDOLES; MALE; REFERENCE VALUES; SEROTONIN AGONISTS;

EID: 0031412762     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90050-3     Document Type: Article

References (31)

1. 4 receptor coupled to adenylyl cyclase stimulation in human brain. Life Sci 1993;52:61-5.
2. 4 receptor. J Pharmacol Exp Ther 1990;252:1378-86.
3. 4-like receptor in human right atrium. Naunyn Schmiedebergs Arch Pharmacol 1991;344:150-9.
4. 4 receptor mediating tachycardia in the pig. Br J Pharmacol 1991;102:107-12.
5. 4 receptors: physiology, pharmacology and therapeutic potential. Exp Opin Invest Drugs 1996; 5:373-88.
6. 4 receptors and gastrointestinal prokinetic action. Pharm Res 1991;24:5-14.
7. 4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 1992;345: 270-5.
8. Tam FSF, Hillier K, Bunce KT. Characterization of the 5-hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colon circular muscle. Br J Pharmacol 1994;113:143-50.
9. Talley NJ. Review: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther 1992;6:273-89.
10. Dhasmana KM, Zhu YN, Cruz SL, Villalón CM. Gastrointestinal effects of 5-hydroxytryptamine and related drugs. Life Sci 1993;53:1651-61.
11. Saxena PR. Serotonin receptors: Subtypes, functional responses and therapeutic relevance. Pharmacol Ther 1995;66:339-68.
12. 4 receptor; 1: design of a new class of agonists and receptor map of the agonist recognition site. J Med Chem 1995;38: 2326-30.
13. 4 receptor; 2: structure-activity studies of the indole carbazimidamide class of agonists. J Med Chem 1995;38: 2331-8.
14. Pfannkuche HJ, Buhl T, Gamse R, Hoyer D, Mattes H, Buchheit KH. The properties of a new prokinetically active drug: SDZ HTF 919 [abstract]. Neurogastroenterol Motil 1995;7:280.
15. 4 receptor agonist stimulates transmitter release and activates the intestinal peristaltic reflex [abstract]. Gastroenterology 1996;110:A1075.
16. 4 agonist, stimulates canine colonie motility and transit in vivo [abstract]. Gastroenterology 1996;110:A724.
17. Sanger GJ, Wardle KA, Shapcott S, Yee KF. In: Fozard JR, Saxena PR, editors. Serotonin: molecular biology, receptors and functional effects Basel: Birkhäuser Verlag; 1991. p. 381-8.
18. 4 receptor agonist. J Clin Pharmacol 1997;37:229-37.
19. Meier R, Beglinger C, Schneider H, Rowedder A, Gyr K. Effect of a liquid diet with and without soluble fiber supplementation on intestinal transit and cholecystokinin release in volunteers. J Parenter Enterai Nutr 1993;17:231-5.
20. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterology 1987;92: 40-7.
21. Meier R, Beglinger C, Dederding JP, Meyer-Wyss B, Fumagalli M, Rowedder A, et al. Alters- und geschlechtsspezifische Normwerte der Dickdarmtransitzeit bei Gesunden. Schweiz Med Wochenschr 1992; 122:940-3.
22. Chaussade S, Roche H, Khyari A, Couturier D, Guerre J. Mesure du temps de transit colique (TTC): description et validation d'une nouvelle technique. Gastroenterol Clin Biol 1986;10:385-9.
23. Dorval D, Barbieux JP, Picon L, Alison D, Codjovi P, Rouleau P. Mesure simplifiée du temps de transit colique par une seule radiographie de l'abdomen et un seul type marqueur, Gastroenterol Clin Biol 1994; 18:141-4.
24. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, NJ: Prentice Hall; 1984.
25. Van der Velde EA. Orthogonal regression equation. In: Van den Besselaar AMHP, Gralnick HR, Lewis SM, editors. Thromboplastin calibration and oral anticoagulant control. Amsterdam: Martinus Nijhoff; 1984. p. 25-39.
26. Kamm MA. The small intestine and colon: scintigraphic quantitation of motility in health and disease. Eur J Nucl Med 1992;19:902-12.
27. Frankenfield DC, Beyer PL. Dietary fiber and bowel function in tube-fed patients. J Am Diet Assoc 1991; 91:590-6.
28. Lampe J, Effertz M, Larson J, Slavin J. Effects of soluble and insoluble dietary fiber on transit time, stool weight and pH in healthy men [abstract]. FASEB J 1991;5:A569.
29. Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG. Absorption of short-chain fatty acids by the colon. Gastroenterology 1980;78:1500-7.
30. Schindlbeck NE, Klauser AG, Müller-Lissner SA. Messung der Kolontransitzeit. Z Gastroenterol 1990; 28:399-404.
31. Arhan P, Devroede G, Jehannin B, Lanza M, Faverdin C, Dornic C, et al. Segmental colonic transit time. Dis Colon Rectum 1981;24:625-9.